Guyene TT - Search Results

1

Influence of the M235T polymorphism of human angiotensinogen (AGT) on plasma AGT and renin concentrations after ethinylestradiol administration.

Azizi M, Hallouin MC, Jeunemaitre X, Guyene TT, Ménard J. Azizi M, et al. Among authors: guyene tt. J Clin Endocrinol Metab. 2000 Nov;85(11):4331-7. doi: 10.1210/jcem.85.11.6932. J Clin Endocrinol Metab. 2000. PMID: 11095476

2

Selective recognition of M235T angiotensinogen variants and their determination in human plasma by monoclonal antibody-based immunoanalysis.

Cohen P, Badouaille G, Gimenez-Roqueplo AP, Mani JC, Guyene TT, Jeunemaitre X, Menard J, Corvol P, Pau B, Simon D. Cohen P, et al. Among authors: guyene tt. J Clin Endocrinol Metab. 1996 Oct;81(10):3505-12. doi: 10.1210/jcem.81.10.8855793. J Clin Endocrinol Metab. 1996. PMID: 8855793

3

Inhibition of human plasma renin activity by pepstatin.

Guyene TT, Devaux C, Menard J, Corvol P. Guyene TT, et al. J Clin Endocrinol Metab. 1976 Dec;43(6):1301-6. doi: 10.1210/jcem-43-6-1301. J Clin Endocrinol Metab. 1976. PMID: 12191

4

Renin release regulation during acute renin inhibition in normal volunteers.

Ménard J, Guyene TT, Chatellier G, Kleinbloesem CH, Bernadet P. Ménard J, et al. Among authors: guyene tt. Hypertension. 1991 Sep;18(3):257-65. doi: 10.1161/01.hyp.18.3.257. Hypertension. 1991. PMID: 1889841 Clinical Trial.

5

Plasma angiotensins, renin, and blood pressure during acute renin inhibition by CGP 38 560A in hypertensive patients.

Jeunemaître X, Ménard J, Nussberger J, Guyene TT, Brunner HR, Corvol P. Jeunemaître X, et al. Among authors: guyene tt. Am J Hypertens. 1989 Nov;2(11 Pt 1):819-27. doi: 10.1093/ajh/2.11.819. Am J Hypertens. 1989. PMID: 2686709

6

Commentary: renin assays: a debate for clinicians, not only for specialists.

Ménard J, Guyene TT. Ménard J, et al. Among authors: guyene tt. J Hypertens. 1995 Mar;13(3):367-9. J Hypertens. 1995. PMID: 7622858 No abstract available.

7

Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.

Azizi M, Chatellier G, Guyene TT, Murieta-Geoffroy D, Ménard J. Azizi M, et al. Among authors: guyene tt. Circulation. 1995 Aug 15;92(4):825-34. doi: 10.1161/01.cir.92.4.825. Circulation. 1995. PMID: 7641363 Clinical Trial.

8

Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects.

Lachurié ML, Azizi M, Guyene TT, Alhenc-Gelas F, Ménard J. Lachurié ML, et al. Among authors: guyene tt. Circulation. 1995 Jun 15;91(12):2933-42. doi: 10.1161/01.cir.91.12.2933. Circulation. 1995. PMID: 7796503

9

Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.

Azizi M, Guyene TT, Chatellier G, Ménard J. Azizi M, et al. Among authors: guyene tt. J Hypertens. 1994 Apr;12(4):419-27. J Hypertens. 1994. PMID: 8064166 Clinical Trial.

10

Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline.

Azizi M, Rousseau A, Ezan E, Guyene TT, Michelet S, Grognet JM, Lenfant M, Corvol P, Ménard J. Azizi M, et al. Among authors: guyene tt. J Clin Invest. 1996 Feb 1;97(3):839-44. doi: 10.1172/JCI118484. J Clin Invest. 1996. PMID: 8609242 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters